Hostname: page-component-cd9895bd7-p9bg8 Total loading time: 0 Render date: 2024-12-19T10:01:01.130Z Has data issue: false hasContentIssue false

P01-258 - Child OCD- Therapeutic Approach. A Case Report

Published online by Cambridge University Press:  17 April 2020

P. Tsitsi
Affiliation:
Acute Ward, Psychiatric Hospital of Petra Olympus, Katerini, Greece
P. Roboti
Affiliation:
Child/Adolescent Clinic, Community Mental Health Center, Psyciatric Hospital of Petra Olympus, Katerini, Greece
N. Voura
Affiliation:
Acute Ward, Psychiatric Hospital of Petra Olympus, Katerini, Greece
K. Papanikolaou
Affiliation:
Acute Ward, Psychiatric Hospital of Petra Olympus, Katerini, Greece
G.F. Angelidis
Affiliation:
Community Mental Health Center, Psychiatric Hospital of Petra Olympus, Katerini, Greece

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Objective

Obsessive Compulsive Disorder (OCD) is an anxiety disorder characterized by obsessions and compulsions, actions which disrupt everyday functioning, and is frequently recognized in youth. Selective Serotonin Reuptake Inhibitors (SSRIs) are widely recommended as first-line pharmacotherapy.

The aim of this presentation is to demonstrate Escitalopram monotherapy in juvenile with OCD.

Method/material

The material used comes from the archives of the Child/Adolescent Clinic of the Community Mental Health Center (CMHC) of Katerini, Greece.

Discussion/results

A 9-year-old child was referred to the Child/Adolescent Clinic of the CMHC. The patient presented unwelcome repeated thoughts that induced anxiety symptoms while at the same time he performed several actions (compulsions) to neutralize his obsessions. From his history, a mood disorder episode was described at simultaneously with the onset of OCD. Then, the patient was admitted in a General Hospital (for a month) and was treated with Fluoxetine on and off for several years. Due to relapse of the symptoms, Risperidone was introduced (1mg/day). The scheme was not beneficial enough, so another SSRI (Escitalopram) was initiated while Risperidone was withdrawn gradually. Six months after the initiation of Escitalopram, the patient's situation is stable, the obsessions and compulsions have been restricted and he appears in better mood.

Conclusions

Monotherapy with Escitalopram seems to provide significant levels of symptomatic improvement in cases of OCD in juvenile producing effective results to this young patient.

Type
Child and adolescent psychiatry
Copyright
Copyright © European Psychiatric Association 2010
Submit a response

Comments

No Comments have been published for this article.